Search research articles
Contact Us
Filters
Showing results (11-20 of 84) with videos related to
Page
of 9
Sort By:
Life (Basel, Switzerland)
|
September 28, 2024
Tracing In-Hospital COVID-19 Outcomes: A Multistate Model Exploration (TRACE)
Hamed Mohammadi, Hamid Reza Marateb, Mohammadreza Momenzadeh, et al.
Age and Ageing
|
September 9, 2010
Predictors of long-term survival in nonagenarians: the NonaSantfeliu study
Francesc Formiga, Assumpta Ferrer, David Chivite, et al.
Aging Clinical and Experimental Research
|
November 1, 2015
Lymphopenia as prognostic factor for mortality and hospital length of stay for elderly hospitalized patients
Manuel Rubio-Rivas, Francesc Formiga, Sara Grillo, et al.
Medicina Clinica
|
March 10, 2012
[Proliferative mesangial lupus nephritis: description of a cohort of 27 patients]
Manuel Rubio-Rivas, Joan Gómez-Junyent, Antonella Simonetti, et al.
Medicina Clinica
|
March 10, 2012
[Hyponatremia in elderly patients admitted in an acute geriatric care unit. prevalence and prognosis]
Manuel Rubio-Rivas, Francesc Formiga, Sandra Cuerpo, et al.
BMC Medical Research Methodology
|
September 2, 2023
Target trial emulation with multi-state model analysis to assess treatment effectiveness using clinical COVID-19 data
Oksana Martinuka, Derek Hazard, Hamid Reza Marateb, et al.
Medicina Clinica
|
December 6, 2006
[Early virologic response value as predictive factor of sustained virologic response to treatment with interferon alpha-2b plus ribavirin in chronic hepatitis C patients with or without HIV coinfection]
Juan Buenestado-García, Manuel Rubio-Rivas, Josep Maria Reñé-Espinet, et al.
Frontiers in Medicine
|
April 5, 2024
Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential
Oksana Martinuka, Derek Hazard, Hamid Reza Marateb, et al.
Journal of Clinical Medicine
|
October 13, 2021
High-Dose Methylprednisolone Pulses for 3 Days vs. Low-Dose Dexamethasone for 10 Days in Severe, Non-Critical COVID-19: A Retrospective Propensity Score Matched Analysis
José María Mora-Luján, Manel Tuells, Abelardo Montero, et al.
Pharmacotherapy
|
September 24, 2021
Beneficial and harmful outcomes of tocilizumab in severe COVID-19: A systematic review and meta-analysis
Manuel Rubio-Rivas, Carlos G Forero, José María Mora-Luján, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 84) with videos related to
Sort By:
Page
of 9
Life (Basel, Switzerland)
|
September 28, 2024
Tracing In-Hospital COVID-19 Outcomes: A Multistate Model Exploration (TRACE)
Hamed Mohammadi, Hamid Reza Marateb, Mohammadreza Momenzadeh, et al.
Age and Ageing
|
September 9, 2010
Predictors of long-term survival in nonagenarians: the NonaSantfeliu study
Francesc Formiga, Assumpta Ferrer, David Chivite, et al.
Aging Clinical and Experimental Research
|
November 1, 2015
Lymphopenia as prognostic factor for mortality and hospital length of stay for elderly hospitalized patients
Manuel Rubio-Rivas, Francesc Formiga, Sara Grillo, et al.
Medicina Clinica
|
March 10, 2012
[Proliferative mesangial lupus nephritis: description of a cohort of 27 patients]
Manuel Rubio-Rivas, Joan Gómez-Junyent, Antonella Simonetti, et al.
Medicina Clinica
|
March 10, 2012
[Hyponatremia in elderly patients admitted in an acute geriatric care unit. prevalence and prognosis]
Manuel Rubio-Rivas, Francesc Formiga, Sandra Cuerpo, et al.
BMC Medical Research Methodology
|
September 2, 2023
Target trial emulation with multi-state model analysis to assess treatment effectiveness using clinical COVID-19 data
Oksana Martinuka, Derek Hazard, Hamid Reza Marateb, et al.
Medicina Clinica
|
December 6, 2006
[Early virologic response value as predictive factor of sustained virologic response to treatment with interferon alpha-2b plus ribavirin in chronic hepatitis C patients with or without HIV coinfection]
Juan Buenestado-García, Manuel Rubio-Rivas, Josep Maria Reñé-Espinet, et al.
Frontiers in Medicine
|
April 5, 2024
Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential
Oksana Martinuka, Derek Hazard, Hamid Reza Marateb, et al.
Journal of Clinical Medicine
|
October 13, 2021
High-Dose Methylprednisolone Pulses for 3 Days vs. Low-Dose Dexamethasone for 10 Days in Severe, Non-Critical COVID-19: A Retrospective Propensity Score Matched Analysis
José María Mora-Luján, Manel Tuells, Abelardo Montero, et al.
Pharmacotherapy
|
September 24, 2021
Beneficial and harmful outcomes of tocilizumab in severe COVID-19: A systematic review and meta-analysis
Manuel Rubio-Rivas, Carlos G Forero, José María Mora-Luján, et al.
Page
of 9